Home/Filings/4/0001415889-24-008762
4//SEC Filing

Zojwalla Naseem 4

Accession 0001415889-24-008762

CIK 0001750284other

Filed

Mar 19, 8:00 PM ET

Accepted

Mar 20, 5:30 PM ET

Size

7.0 KB

Accession

0001415889-24-008762

Insider Transaction Report

Form 4
Period: 2024-03-18
Zojwalla Naseem
CHIEF MEDICAL OFFICER
Transactions
  • Exercise/Conversion

    Common Stock

    2024-03-18$4.87/sh+13,700$66,71980,364 total
  • Exercise/Conversion

    Stock Option (Right to Buy)

    2024-03-1813,700136,300 total
    Exercise: $4.87Exp: 2033-01-31Common Stock (13,700 underlying)
Footnotes (1)
  • [F1]25% of the shares subject to the option vested on February 1, 2024 and 1/48 of the total number of shares subject to the option vest each month thereafter, subject to the Reporting Person's continuous service through each applicable vesting date.

Issuer

Olema Pharmaceuticals, Inc.

CIK 0001750284

Entity typeother

Related Parties

1
  • filerCIK 0001905871

Filing Metadata

Form type
4
Filed
Mar 19, 8:00 PM ET
Accepted
Mar 20, 5:30 PM ET
Size
7.0 KB